Cascades Capital Asset Management, LLC Milestone Pharmaceuticals Inc. Transaction History
Cascades Capital Asset Management, LLC
- $227 Billion
- Q3 2025
A detailed history of Cascades Capital Asset Management, LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Cascades Capital Asset Management, LLC holds 77,335 shares of MIST stock, worth $159,310. This represents 0.07% of its overall portfolio holdings.
Number of Shares
77,335
Previous 67,135
15.19%
Holding current value
$159,310
Previous $130 Million
18.76%
% of portfolio
0.07%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding MIST
# of Institutions
68Shares Held
38.4MCall Options Held
111KPut Options Held
270K-
Adage Capital Partners Gp, L.L.C. Boston, MA6.98MShares$14.4 Million0.02% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA5.12MShares$10.6 Million10.26% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$10.2 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.22MShares$6.64 Million0.22% of portfolio
-
Morgan Stanley New York, NY2.97MShares$6.12 Million0.0% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $61.8M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...